Free Trial

Cardiff Oncology (CRDF) Earnings Date, Estimates & Call Transcripts

Cardiff Oncology logo
$2.92 -0.16 (-5.05%)
As of 01:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cardiff Oncology Earnings Summary

Cardiff Oncology issued Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.20, which missed analysts' consensus estimates of -$0.19 by $0.01. Quarterly revenue was reported to be $0.11 million, above the consensus estimate of $0.09 million. With a trailing EPS of -$0.92, Cardiff Oncology's earnings are expected to grow next year, from ($0.99) to ($0.94) per share.

Latest Q1
Earnings Date
May. 8Estimated
Consensus EPS
(May. 8)
-$0.19
Actual EPS
(May. 8)
-$0.20 Missed By -$0.01
Actual Revenue
(May. 8)
$0.11M

Q1 2025 Earnings Resources

Get Cardiff Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cardiff Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CRDF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRDF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cardiff Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.28-$0.28-$0.28
Q2 20251-$0.27-$0.27-$0.27
Q3 20251-$0.31-$0.31-$0.31
Q4 20251-$0.31-$0.31-$0.31
FY 2025 4 -$1.17 -$1.17 -$1.17
Q1 20261-$0.26-$0.26-$0.26
Q2 20261-$0.26-$0.26-$0.26
Q3 20261-$0.28-$0.28-$0.28
Q4 20261-$0.28-$0.28-$0.28

Cardiff Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025-$0.19-$0.20 -$0.01-$0.20$0.09M$0.11M
11/7/2024--$0.27-$0.25+$0.02-$0.25$0.13M$0.17M
8/8/2024Q2 2024-$0.25-$0.26 -$0.01-$0.26$0.12M$0.16M
5/2/2024Q1 2024-$0.25-$0.22+$0.03-$0.22$0.11M$0.21M
2/29/2024Q4 2023-$0.26-$0.21+$0.05-$0.21$0.08M$0.16M
11/2/2023Q3 2023-$0.29-$0.22+$0.07-$0.22$0.08M$0.14M
8/9/2023Q2 2023-$0.27-$0.25+$0.02-$0.25$0.08M$0.11M

Cardiff Oncology Earnings - Frequently Asked Questions

Cardiff Oncology (NASDAQ:CRDF) last announced its quarterly earning data on Thursday, May 8, 2025. Learn more on CRDF's earnings history.

In the previous quarter, Cardiff Oncology (NASDAQ:CRDF) missed the analysts' consensus estimate of ($0.19) by $0.01 with a reported earnings per share (EPS) of ($0.20). Learn more on analysts' earnings estimate vs. CRDF's actual earnings.

Cardiff Oncology (NASDAQ:CRDF) has a recorded annual revenue of $587,000.00.

Cardiff Oncology (NASDAQ:CRDF) has a recorded net income of -$41.44 million. CRDF has generated -$0.92 earnings per share over the last four quarters.

Cardiff Oncology's earnings are expected to grow from ($0.99) per share to ($0.94) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CRDF) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners